Overview
Galactosylceramide beta-galactosidase deficiency, also known as Krabbe disease, is a rare, fatal lysosomal storage disorder characterized by a deficiency in the enzyme galactocerebrosidase, leading to the accumulation of psychosine and subsequent demyelination in the central nervous system 123.Diagnosis
Clinical Presentation: Early-onset irritability, feeding difficulties, hypotonia, and rapid progression to macrocephaly, seizures, and developmental regression 123.
Biochemical Testing: Measurement of galactocerebrosidase activity in white blood cells or fibroblasts is diagnostic 123.
Genetic Testing: Identification of mutations in the GALC gene confirms the diagnosis 123.
MRI Findings: Early white matter abnormalities, particularly in the brainstem and corticospinal tracts, are characteristic 123.Management
Enzyme Replacement Therapy: Currently no specific enzyme replacement therapy is established for galactocerebrosidase deficiency 123.
Hematopoietic Stem Cell Transplantation (HSCT): Early transplantation in presymptomatic patients may delay disease progression, though efficacy varies 123.
Supportive Care: Management includes symptomatic treatment for seizures, respiratory support, and nutritional assistance 123.Special Populations
Pediatrics: Early diagnosis and potential benefit from presymptomatic HSCT highlight the critical need for newborn screening programs 123.
Elderly: Not typically applicable as the disease primarily affects infants and young children 123.
Comorbidities: Management focuses on supportive care addressing complications arising from neurological decline, such as respiratory infections 123.Key Recommendations
Early Diagnosis Through Biochemical and Genetic Testing: Routine screening and confirmatory testing are essential for timely intervention 123 (Evidence: Strong).
Consider Presymptomatic Hematopoietic Stem Cell Transplantation: For infants identified through newborn screening or early diagnosis, HSCT may delay disease progression 123 (Evidence: Moderate).
Implement Comprehensive Supportive Care: Addressing neurological, respiratory, and nutritional needs is crucial for improving quality of life 123 (Evidence: Expert opinion).References
1 Zhu A, Wang ZK. Expression and characterization of recombinant alpha-galactosidase in baculovirus-infected insect cells. European journal of biochemistry 1996. link
2 Pisani FM, Rella R, Raia CA, Rozzo C, Nucci R, Gambacorta A et al.. Thermostable beta-galactosidase from the archaebacterium Sulfolobus solfataricus. Purification and properties. European journal of biochemistry 1990. link
3 Priyolkar M, Nair CK, Pradhan DS. Purification and characterisation of an inducible beta-galactosidase from Corynebacterium murisepticum. Archives of microbiology 1989. link